A new phenolic acid isolated from Salvia miltiorrhiza ameliorates OVA-induced allergic asthma by regulation of Th17/Treg cells and inflammation through the TLR4 pathway
- 13 December 2025
- journal article
- Published by Elsevier in Chinese Journal of Natural Medicines
- Vol. 23 (12) , 100007
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 33 references indexed in Scilit:
- Nasal epithelial gene expression and total IgE in children and adolescents with asthmaJournal of Allergy and Clinical Immunology, 2023
- Assessing prescriber adherence with Global Initiative for Asthma (GINA) guideline-recommended reliever therapyInternal and Emergency Medicine, 2023
- Diterpenoid quinones from the Salvia miltiorrhiza and their lung protective activityFitoterapia, 2023
- T-cell responses in asthma exacerbationsAnnals of Allergy, Asthma & Immunology, 2022
- The basic immunology of asthmaCell, 2021
- Mast Cell-Mediated Orchestration of the Immune Responses in Human Allergic Asthma: Current InsightsClinical Reviews in Allergy & Immunology, 2018
- Airway remodeling in asthma: what really mattersCell and tissue research, 2017
- Epithelial barrier function: At the front line of asthma immunology and allergic airway inflammationJournal of Allergy and Clinical Immunology, 2014
- Innate immune cells in asthmaTrends in Immunology, 2013
- Angiogenesis and Vascular Remodeling in Chronic Airway DiseasesCell Biochemistry and Biophysics, 2013